Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Selective Na(V)1.7 channel inhibitor shows promise as an analgesic

Aug. 28, 2012

Multiple novel CCR2 receptor antagonists synthesized at Janssen

Aug. 28, 2012

Abbott presents discovery of multiple HCV NS5B inhibitors

Aug. 27, 2012

Chugai presents new highly potent and selective AXL inhibitor

Aug. 27, 2012

New SPT inhibitor selected for further development in hepatitis C

Aug. 24, 2012

New BACE inhibitor reduces CNS beta-amyloid in vivo

Aug. 24, 2012

Amgen products target free fatty acid FFA1 receptor for diabetes

Aug. 24, 2012

Dual-action AT1 receptor antagonist/PPAR-gamma agonist selected as clinical candidate

Aug. 24, 2012

Takeda presents new potent IAP inhibitors with promising oncolytic activity

Aug. 23, 2012

HTS hit-to-lead discovery program yields new GSK-3 beta inhibitors

Aug. 23, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....